Quantcast

Latest ViaCyte Inc. Stories

2014-12-18 08:28:46

Induced immune tolerance may reduce the need for long-term immunosuppression SAN DIEGO, Dec. 18, 2014 /PRNewswire/ -- ViaCyte, Inc.

2014-10-29 08:34:57

First Ever Person with Type 1 Diabetes Receives Experimental Encapsulated Human Stem Cell-Derived Beta Cell Replacement Therapy NEW YORK, Oct.

2014-08-19 08:30:47

Company Plans to Immediately Initiate Phase 1/2 Clinical Trial SAN DIEGO, Aug.

2014-07-17 16:25:37

NEW YORK, July 17, 2014 /PRNewswire/ -- JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research announced today ViaCyte, Inc., a leading regenerative medicine


Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.